Optimum Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-125
Closed -$27K 948
2020
Q4
$27K Hold
125
0.01% 582
2020
Q3
$21K Buy
+125
New +$23.1K 0.01% 600
2020
Q1
Sell
-500
Closed -$77K 934
2019
Q4
$77K Hold
500
0.02% 432
2019
Q3
$68K Hold
500
0.02% 450
2019
Q2
$61K Sell
500
-64
-11% -$7.09K 0.02% 468
2019
Q1
$59K Hold
564
0.02% 475
2018
Q4
$64K Hold
564
0.02% 426
2018
Q3
$65K Hold
564
0.02% 482
2018
Q2
$58K Hold
564
0.02% 502
2018
Q1
$56K Buy
+564
New +$53.3K 0.02% 512
2015
Q1
$215K Hold
3,000
0.07% 274
2014
Q4
$168K Hold
3,000
0.05% 295
2014
Q3
$148K Hold
3,000
0.05% 302
2014
Q2
$152K Hold
3,000
0.05% 295
2014
Q1
$134K Hold
3,000
0.05% 268
2013
Q4
$141K Hold
3,000
0.05% 255
2013
Q3
$158K Buy
+3,000
New +$146K 0.06% 232

Other funds holding RMD

Optimum Investment Advisors's RMD Position: Q1 2021 in Review

Optimum Investment Advisors sold out of ResMed (RMD) in Q1 2021, closing a stake of 125 shares — an estimated $27K sold.

Optimum Investment Advisors first reported a position in RMD in Q3 2013 and held it in 17 quarters. The position peaked at $215K in Q1 2015. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Optimum Investment Advisors reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
  • Optimum Investment Advisors sold 125 ResMed shares in Q1 2021, an estimated $27K.
  • Optimum Investment Advisors first reported a position in ResMed in Q3 2013 and held it in 17 quarters.
  • Optimum Investment Advisors's ResMed position peaked at $215K in Q1 2015.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Optimum Investment Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.